International Journal of Cardiology
Volume 131, Issue 3 , Pages 421-423, 24 January 2009

Increased interleukin-13 levels in patients with chronic heart failure

  • Yuki Nishimura

      Affiliations

    • Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
  • ,
  • Teruo Inoue

      Affiliations

    • Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    • Corresponding Author InformationCorresponding author. 5-1-1 Nabeshima, Saga 849-8501, Japan. Tel.: +81 95 234 3536; fax: +81 95 234 2089.
  • ,
  • Takeaki Nitto

      Affiliations

    • Department of Advanced Heart Research, Saga University Faculty of Medicine, Saga, Japan
  • ,
  • Toshifumi Morooka

      Affiliations

    • Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
  • ,
  • Koichi Node

      Affiliations

    • Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan

Received 16 May 2007; received in revised form 6 July 2007; accepted 7 July 2007. published online 22 November 2007.

Abstract 

A great number of basic and clinical studies have demonstrated that inflammatory cytokines play an important role in development and progress of heart failure. However, there is limited information about allergic cytokine interleukin-13 (IL-13). The inflammatory responses mediated by allergic cytokines can cause significant morbidity and mortality when they become chronic. Therefore, we elucidated the role of IL-13 in the pathophysiology of chronic heart failure. We measured plasma IL-13 levels by enzyme-linked immunosorbent assay in 110 patients with chronic heart failure and 20 control subjects. Plasma IL-13 levels were increased in heart failure patients, compared with the controls, in association with NYHA functional class. In addition, IL-13 levels were correlated positively with plasma levels of brain natriuretic peptide and C-reactive protein, and negatively with left ventricular ejection fraction. Plasma IL-13 levels may be useful for evaluating disease severity in chronic heart failure.

Keywords: Heart failure, Interleukin-13, Inflammation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-5273(07)01715-9

doi:10.1016/j.ijcard.2007.07.128

International Journal of Cardiology
Volume 131, Issue 3 , Pages 421-423, 24 January 2009